Form 4: HealthEquity Executive Delano Ladd Sells Shares Under 10b5-1 Trading Plan

Delano Ladd, EVP, GC & Corporate Secretary of HealthEquity, Inc., sold 2,558 shares of common stock at $82.59 per share on March 1, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 1, 2024, Delano Ladd, the EVP, GC & Corporate Secretary of HealthEquity, Inc., sold 2,558 shares of the company's common stock.
• The sale was executed at a price of $82.59 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on September 22, 2023.
• Following the transaction, Ladd directly owns 47,438 shares of HealthEquity, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an executive's stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock sales are a common occurrence and are often part of a pre-planned diversification strategy or to cover tax obligations. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The stock sale by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates